Thanks for posting it here. Here’s my reply to the same basher who also said cisplatin wasn’t mentioned in the trial design.

Quote:

---

4. Have a plan to receive a standard cisplatin chemotherapy regimen administered weekly (30-40 mg/m2) or approximately every 21 days (80-100 mg/m2)

https://clinicaltrials.gov/ct2/show/NCT023243...amp;rank=6

Subgroup analysis helps the design for Phase 3 and increases its odds of success.

It’s a desperate attempt to use the term “cherry picking” because that strategy is often used for failed trials.

---